1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Mechanisms of adoptive T cell micropharmacies
    Meeting Abstract

    Bourne, C.; Gardner, T.; Romero-Pichardo, J.; Lee, P.; Dacek, M.; Tan, D.; Scheinberg, D.
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Metastatic neuroblastoma of the frontal scalp in an adult: A case report
    Meeting Abstract

    Saleh, J.; Antonescu, C.; Pytel, P.; Pambuccian, S.; Borys, E.; Prabhu, V.
    Journal of Neuropathology and Experimental Neurology (2020)

    Fulltext@MSK | Save
  • Young-onset pancreas cancer (PC) in patients less than or equal to 50 years old at Memorial Sloan Kettering (MSK): Descriptors, genomics, and outcomes
    Meeting Abstract

    Varghese, A. M.; Singh, I.; Singh, R. R.; Capanu, M.; Chou, J. F.; Wong, W.; Stadler, Z. K.; Salo-Mullen, E. E.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic correlates of extreme pathologic response following neoadjuvant chemotherapy in locally advanced gastric cancer to reveal distinct vulnerabilities
    Meeting Abstract

    Datta, J.; Walch, H. S.; Russo, A.; Chatila, W. K.; Vos, E.; Bhanot, U.; Janjigian, Y. Y.; Schultz, N.; Tang, L. H.; Strong, V. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic characterization of rectal cancer and molecular determinants of response to neoadjuvant chemoradiotherapy
    Meeting Abstract

    Chatila, W. K.; Marco, M.; Qu, X.; Walch, H. S.; Luthra, A.; Chen, C. T.; Kundra, R.; Schultz, N.; Yaeger, R.; Smith, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Wang, X.; Zabierowski, S.; Wu, M.; Del Casale, C.; Eyquem, J.; Mansilla-Soto, J.; Riviere, I.; Sadelain, M.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save